Table 2.
Number and Timing of DEX Implant Treatments
| Parameter | Total Population (n = 700) | BRVO (n = 554) | CRVO (n = 146) |
|---|---|---|---|
| Number of DEX implant injections, n (%) | |||
| ≥1 | 700 | 554 | 146 |
| ≥2 | 70 | 50 | 20 |
| ≥3 | 10 | 8 | 2 |
| ≥4 | 3 | 2 | 1 |
| For patients who received second injection (n= 70 total): | |||
| Mean (SD) days from first to second injection | 101.6 (63.4) | 90.2 (66.1) | 130.0 (46.3) |
| For patients who received third injection (n= 10 total): | |||
| Mean (SD) days from first to third injection | 157.6 (90.9) | 145.1 (79.4) | 207.5 (154.9) |
| Mean (SD) days from second to third injection | 91.8 (69.4) | 90.9 (76.7) | 95.5 (46.0) |
Abbreviations: BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion; DEX implant, dexamethasone intravitreal implant; SD, standard deviation.